Rapamycin for Longevity

Low-dose rapamycin as an off-label longevity intervention, clinical evidence, and safety debates.

Key developments include clinical evidence for off-label rapamycin as a longevity drug remains limited, among other significant events and policy changes.

Source: Geo Health Space